Hazany, DeClouette, Lowe, Hwang, Kim, Bluml, and Partikian: Corrigendum to: Glutathione Increase and Seizure Burden Decrease in Patients with Intractable Epilepsy on Ketogenic Diet
Corrigendum

Journal of Epilepsy Research 2023; 13(2): 63-64.

Published online: December 31, 2023

DOI: https://doi.org/10.14581/jer.23001.e1

Corrigendum to: Glutathione Increase and Seizure Burden Decrease in Patients with Intractable Epilepsy on Ketogenic Diet

Saman Hazany, MD1, Brittany DeClouette, MD1, Jessica Lowe, MPH2, Darryl H Hwang, PhD1, Paul E Kim, MD1, Stefan Bluml, PhD3, Arthur Partikian, MD2

1Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

2Department of Pediatrics & Neurology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

3Department of Radiology, Children’s Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

Copyright © 2023 Korean Epilepsy Society

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
J Epilepsy Res 2023;13(1):1-6
In published article by Hazany S et al., there is an error in the data value and location of the ‘Absolute level’ column in Table 1. Modify the data values and locations as follows.
Before correction:
Patient Clinical data MRS data
Age (years) Seizures (months) Average seizure duration (minutes) Diet duration (months) Serum βHB (mM/L) GSH (parietal white matter) NAA/tCr βHB absolute level (IU)
Absolute level (IU) GSH/tCr
1
 Pre-KD 42 3–5 1–5 4 0.15 0.02 GM: 1.46 GM: 0.49
GM: 0.12 (SD: 268)
WM: 0.65 (SD: 56) 0.07 WM: 1.30 WM: 0.00
 Post-KD 1–2 0.5 0.12 0.33 GM: 1.57 GM: 0.07
GM: 1.40 (SD: 35)
WM: 1.50 (SD: 31) 0.19 WM: 1.28 WM: 0.02
2
 Pre-KD 35 2–4 2–5 7 0.10 0.02 GM: 1.39 GM: 0.68
GM: 0.10 (SD: 370)
WM: 0.80 (SD: 39) 0.12 WM: 1.42 WM: 0.25
 Post-KD 1–2 0.5 0.10–0.18 0.15 GM: 1.46 GM: 0.25
GM: 0.70 (SD: 51)
WM: 2.00 (SD: 16) 0.35 WM: 1.40 WM: 0.56
After correction:
Patient Clinical data MRS data
Age (years) Seizures (months) Average seizure duration (minutes) Diet duration (months) Serum βHB (mM/L) GSH (parietal white matter) NAA/tCr βHB absolute level (IU)
Absolute level (IU) GSH/tCr
1
 Pre-KD 42 3–5 1–5 4 0.15 GM: 0.12 (SD: 268) 0.02 GM: 1.46 GM: 0.49
WM: 0.65 (SD: 56) 0.07 WM: 1.30 WM: 0.00
 Post-KD 1–2 0.5 0.12 GM: 1.40 (SD: 35) 0.33 GM: 1.57 GM: 0.07
WM: 1.50 (SD: 31) 0.19 WM: 1.28 WM: 0.02
2
 Pre-KD 35 2–4 2–5 7 0.10 GM: 0.10 (SD: 370) 0.02 GM: 1.39 GM: 0.68
WM: 0.80 (SD: 39) 0.12 WM: 1.42 WM: 0.25
 Post-KD 1–2 0.5 0.10–0.18 GM: 0.70 (SD: 51) 0.15 GM: 1.46 GM: 0.25
WM: 2.00 (SD: 16) 0.35 WM: 1.40 WM: 0.56
Additionally, the CI abbreviation in Figure 2 of the above article is modified from ‘confidence interval’ to ‘complex I’.
The authors would like to apologize for any inconvenience caused.